H.K. Breddin

1.6k total citations
97 papers, 1.1k citations indexed

About

H.K. Breddin is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, H.K. Breddin has authored 97 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Cardiology and Cardiovascular Medicine, 38 papers in Internal Medicine and 35 papers in Surgery. Recurrent topics in H.K. Breddin's work include Venous Thromboembolism Diagnosis and Management (38 papers), Heparin-Induced Thrombocytopenia and Thrombosis (26 papers) and Antiplatelet Therapy and Cardiovascular Diseases (25 papers). H.K. Breddin is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (38 papers), Heparin-Induced Thrombocytopenia and Thrombosis (26 papers) and Antiplatelet Therapy and Cardiovascular Diseases (25 papers). H.K. Breddin collaborates with scholars based in Germany, Poland and United Kingdom. H.K. Breddin's co-authors include Vijay V. Kakkar, Roumen Nakov, V. Hach-Wunderle, W. Weichert, C.M. Kirchmaier, Ute Klinkhardt, Jochen Graff, S. Harder, Hans Wolf and Helmut Schäfer and has published in prestigious journals such as New England Journal of Medicine, Circulation and Blood.

In The Last Decade

H.K. Breddin

89 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H.K. Breddin Germany 17 565 517 399 398 85 97 1.1k
J.F. Martin United Kingdom 13 534 0.9× 561 1.1× 138 0.3× 254 0.6× 133 1.6× 33 1.3k
V. Hach-Wunderle Germany 15 779 1.4× 403 0.8× 301 0.8× 663 1.7× 35 0.4× 92 1.2k
G. Freyburger France 16 243 0.4× 174 0.3× 187 0.5× 211 0.5× 148 1.7× 34 881
Françoise Bridey France 15 382 0.7× 257 0.5× 711 1.8× 494 1.2× 82 1.0× 36 1.2k
Lars M. Asmis Switzerland 21 296 0.5× 282 0.5× 227 0.6× 233 0.6× 103 1.2× 51 1.2k
Marco J.D. Tangelder Netherlands 20 279 0.5× 593 1.1× 160 0.4× 767 1.9× 474 5.6× 39 1.5k
P Stevens Canada 14 386 0.7× 259 0.5× 379 0.9× 261 0.7× 72 0.8× 21 955
Mateja K. Ježovnik Slovenia 18 285 0.5× 263 0.5× 102 0.3× 332 0.8× 149 1.8× 60 789
C. P. Henny Netherlands 17 98 0.2× 206 0.4× 303 0.8× 305 0.8× 129 1.5× 31 1.1k
E G Bovill United States 13 203 0.4× 375 0.7× 211 0.5× 194 0.5× 123 1.4× 21 968

Countries citing papers authored by H.K. Breddin

Since Specialization
Citations

This map shows the geographic impact of H.K. Breddin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.K. Breddin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.K. Breddin more than expected).

Fields of papers citing papers by H.K. Breddin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.K. Breddin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.K. Breddin. The network helps show where H.K. Breddin may publish in the future.

Co-authorship network of co-authors of H.K. Breddin

This figure shows the co-authorship network connecting the top 25 collaborators of H.K. Breddin. A scholar is included among the top collaborators of H.K. Breddin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.K. Breddin. H.K. Breddin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bauersachs, Rupert & H.K. Breddin. (2004). Moderne Antikoagulation. Der Internist. 45(6). 717–726. 3 indexed citations
2.
Radziwon, Piotr, et al.. (2003). Effects of PEG-Hirudin in Clotting Parameters and Platelet Function and its Interaction with Aspirin in Healthy Volunteers. Clinical and Applied Thrombosis/Hemostasis. 9(1). 79–88. 1 indexed citations
3.
Breddin, H.K., V. Hach-Wunderle, Roumen Nakov, & Vijay V. Kakkar. (2001). Effects of a Low-Molecular-Weight Heparin on Thrombus Regression and Recurrent Thromboembolism in Patients with Deep-Vein Thrombosis. New England Journal of Medicine. 344(9). 626–631. 149 indexed citations
4.
Radziwon, Piotr, et al.. (2000). Platelet activation and its role in thrombin generation in platelet-induced thrombin generation time. Thrombosis Research. 100(5). 419–426. 11 indexed citations
5.
Klinkhardt, Ute, et al.. (2000). Ex vivo?in vitro interaction between aspirin, clopidogrel, and the glycoprotein IIb/IIIa inhibitors abciximab and SR121566A. Clinical Pharmacology & Therapeutics. 67(3). 305–313. 29 indexed citations
7.
Kaiser, Brigitte, Erika Glusa, Debra A. Hoppensteadt, et al.. (1998). A supersulfated low-molecular-weight heparin (IK-SSH) increases plasma levels of free and total tissue factor pathway inhibitor after intravenous and subcutaneous administration in humans. Blood Coagulation & Fibrinolysis. 9(6). 517–524. 7 indexed citations
8.
Schenk, Joachim, et al.. (1996). A Recombinant Hirudin (IK-HIR02) in Healthy Volunteers. Pathophysiology of Haemostasis and Thrombosis. 26(4). 187–194. 7 indexed citations
9.
Schenk, Joachim, et al.. (1996). A Recombinant Hirudin (IK-HIR02) in Healthy Volunteers. Pathophysiology of Haemostasis and Thrombosis. 26(3). 140–149. 10 indexed citations
10.
Kirchmaier, C.M., et al.. (1994). Regression of deep vein thrombosis by I.V.-administration of a low molecular weight heparin-results of a pilot study-. Thrombosis Research. 73(5). 337–348. 13 indexed citations
11.
Nowak‐Göttl, Ulrike, et al.. (1992). Nichtparametrischer Normalbereich für thrombozytäre Parameter im Kindesalter. Klinische Pädiatrie. 204(1). 37–42. 1 indexed citations
12.
Breddin, H.K., et al.. (1992). Individual and Combined Effects of a Thromboxane Receptor Antagonist and Different Antithrombotic Agents in a Rat Microcirculatory Thrombosis Model. Pathophysiology of Haemostasis and Thrombosis. 22(6). 322–329. 3 indexed citations
14.
Breddin, H.K., et al.. (1991). The Effects of Recombinant Hirudin on Various Platelet Functions. Pathophysiology of Haemostasis and Thrombosis. 21(Suppl. 1). 107–115. 2 indexed citations
15.
Kirchmaier, C.M., Markus Meyer, P. Spangenberg, et al.. (1990). Platelet membrane defects in fawn hooded bleeder rats. Thrombosis Research. 57(3). 353–360. 10 indexed citations
16.
Breddin, H.K.. (1989). Current Perspectives in the Antiplatelet Therapy of Thrombotic Disorders. Seminars in Thrombosis and Hemostasis. 15(2). 144–149. 1 indexed citations
17.
Breddin, H.K., et al.. (1989). Antithrombotic Effects of Three Thrombin Inhibitors in a Rat Model of Laser-Induced Thrombosis. Pathophysiology of Haemostasis and Thrombosis. 19(2). 74–82. 20 indexed citations
18.
Weichert, W. & H.K. Breddin. (1989). Effect of Antibiotics on Laser-Induced Thrombus Formation in Rat Mesenteric Arterioles. Pathophysiology of Haemostasis and Thrombosis. 19(4). 224–228. 3 indexed citations
19.
Altorjay, I, C.M. Kirchmaier, & H.K. Breddin. (1989). Changes of spontaneous and induced platelet aggregation in the presence of a human endothelial cell monolayer. Thrombosis Research. 55(1). 69–77. 1 indexed citations
20.
Weichert, W. & H.K. Breddin. (1988). Effect of Low-Molecular-Weight Heparins on Laser-Induced Thrombus Formation in Rat Mesenteric Vessels. Pathophysiology of Haemostasis and Thrombosis. 18(Suppl. 3). 55–63. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026